These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26047574)

  • 21. Role of Rac1 GTPase activation in atrial fibrillation.
    Adam O; Frost G; Custodis F; Sussman MA; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2007 Jul; 50(4):359-67. PubMed ID: 17659204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1.
    Yuan CT; Li XX; Cheng QJ; Wang YH; Wang JH; Liu CL
    Int J Clin Exp Pathol; 2015; 8(12):15527-36. PubMed ID: 26884822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Update: prolonged-release torasemide].
    Acuña C
    Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
    Sun QL; Li M; Rui HL; Chen YP
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid receptor, CYP11B2 mRNA expression, and atrial matrix remodelling in patients with atrial fibrillation.
    Pei DA; Yan YY; Li L; Xu ZY; Huang JY; Wang M; Xu ZM; Yao Q; Huang SE; Huang Q; Wang SS
    Acta Cardiol; 2010 Oct; 65(5):527-33. PubMed ID: 21125974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
    Tsai CT; Chiang FT; Tseng CD; Hwang JJ; Kuo KT; Wu CK; Yu CC; Wang YC; Lai LP; Lin JL
    J Am Coll Cardiol; 2010 Feb; 55(8):758-70. PubMed ID: 20170814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis.
    Angelini A; Li Z; Mericskay M; Decaux JF
    PLoS One; 2015; 10(10):e0139858. PubMed ID: 26440278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of doxycycline on chronic intermittent hypoxia-induced atrial remodeling in rats.
    Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G
    Herz; 2020 Nov; 45(7):668-675. PubMed ID: 30470910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension.
    Hakki T; Hübel K; Waldmann H; Bernhardt R
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):120-8. PubMed ID: 21193036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.
    Qiu H; Wu H; Ma J; Cao H; Huang L; Qiu W; Peng Y; Ding C
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):323-334. PubMed ID: 29290021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
    López B; González A; Beaumont J; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2007 Aug; 50(9):859-67. PubMed ID: 17719472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects.
    Papillon JP; Lou C; Singh AK; Adams CM; Ksander GM; Beil ME; Chen W; Leung-Chu J; Fu F; Gan L; Hu CW; Jeng AY; LaSala D; Liang G; Rigel DF; Russell KS; Vest JA; Watson C
    J Med Chem; 2015 Dec; 58(23):9382-94. PubMed ID: 26540564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo.
    Ries C; Lucas S; Heim R; Birk B; Hartmann RW
    J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):121-6. PubMed ID: 19427380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irregular pacing of ventricular cardiomyocytes induces pro-fibrotic signalling involving paracrine effects of transforming growth factor beta and connective tissue growth factor.
    Slawik J; Adrian L; Hohl M; Lothschütz S; Laufs U; Böhm M
    Eur J Heart Fail; 2019 Apr; 21(4):482-491. PubMed ID: 30675967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-138-5p is downregulated in patients with atrial fibrillation and reverses cardiac fibrotic remodeling via repressing CYP11B2.
    Xie H; Fu JL; Xie C
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4642-4647. PubMed ID: 30058705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
    Watanabe K; Sreedhar R; Thandavarayan RA; Karuppagounder V; Giridharan VV; Antony S; Harima M; Nakamura M; Suzuki K; Suzuki H; Sone H; Arumugam S
    Biofactors; 2017 Mar; 43(2):187-194. PubMed ID: 27662823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
    Chilukoti RK; Mostertz J; Bukowska A; Aderkast C; Felix SB; Busch M; Völker U; Goette A; Wolke C; Homuth G; Lendeckel U
    Int J Cardiol; 2013 Oct; 168(3):2100-8. PubMed ID: 23414741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide.
    Zhu XQ; Hong HS; Lin XH; Chen LL; Li YH
    Braz J Med Biol Res; 2014 Aug; 47(8):646-54. PubMed ID: 25014176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.